Acme India IPO is scheduled to finish bidding on October 6, 2026, according to the company’s September 24 red herring prospectus. The issuer-hosted price-band announcement sets a ₹186–₹196 range and a minimum bid of 1,200 shares. At the cap price, that is a ₹2,35,200 application commitment—not ₹1,17,600 for a single 600-share increment.
Acme India IPO: minimum bid versus increments
CapKet arithmetic: 1,200 multiplied by ₹196 equals ₹2,35,200. At the floor price of ₹186, the same share count represents ₹2,23,200. The advertisement permits subsequent bids in multiples of 600 shares. The minimum and the permitted increment are different instructions; reading only the increment can understate the starting commitment.
The RHP puts the UPI mandate deadline at 5 PM on the closing day. That does not establish your broker’s application cutoff or prove that a mandate has been approved. An application entry, payment mandate and eventual allotment are separate steps. Check the intermediary’s current instructions and the actual mandate status instead of treating submission alone as completion.
Fresh shares and seller shares have different destinations
The documented offer comprises up to 54,07,200 fresh shares and 8,01,600 shares offered for sale, totalling 62,08,800. The proposed listing venue is BSE SME. Issuing fresh shares and selling existing shares are not the same capital transaction.
CapKet explanation: Money raised through the fresh issue goes to the company, after relevant issue expenses; sale proceeds from existing shares go to the selling shareholder. Therefore the total offer value should not be described as the company’s net new funding. At ₹196, multiplying the respective advertised share counts gives approximately ₹105.98 crore for the fresh component and ₹15.71 crore for the sale component. These are cap-price calculations, not final proceeds.
What this closing-day check does not establish
A price band is not a guaranteed listing price. A scheduled close is not confirmation of allotment, exchange trading permission or the first trading session. This report has not verified current subscription figures, grey-market premiums or a later timetable amendment. It does not assess whether the offer is suitable for any reader.
For another example of checking an offer milestone rather than relying on GMP, read our dated SRIT India mandate-deadline report. That September article is historical, not a current offer update.
Primary evidence, observed October 6, 2026 at 14:53 IST: the issuer’s September 24 RHP, cover and offer terms, and September 25 price-band advertisement. Both are linked from the company’s investor-relations page. No independent audit or human editorial approval is claimed.